January 23, 2017 | Two biomed companies, Pluristem Therapeutics Ltd.  and Can-Fite BioPharma Ltd., announced financing rounds at the end of last week. Pluristem raised $15 million, after enlarging its planned offering, while Can-Fite raised $5 million. In May, Pluristem, an Israeli company developing placenta-based therapy products, announced that it was awarded a NIS 12.7 million […]